EMMES BIOPHARMA UK LIMITED
Significant control: Steven Bruce Klinsky (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Emmes Biopharma UK Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Emmes Biopharma UK Limited sell?
Registered activity: Other research and experimental development on natural sciences and engineering (SIC 72190). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
EMMES BIOPHARMA UK LIMITED is an active (proposal to strike off) private limited company (company number 04498663) incorporated on 30 July 2002, registered in Milton Keynes. Its registered activity is other research and experimental development on natural sciences and engineering (SIC 72190). Latest group accounts cover the period ending 31 December 2024, showing net assets of £12.78m and cash of £1.15m, with 31 employees on average. Net assets rose 11% on the prior period (£11.52m).
By net assets it sits in the top quarter of 3,656 comparable companies in the UK (median £559, upper quartile £49k).
Ownership and control
- Mr Steven Bruce Klinsky
- holds 75–100% of voting rights
- Mr Thomas Ogorka
- owns 75–100% of shares
- Mrs Nazira Ogorka
- has significant influence or control
- The Emmes Company, Llc
- owns 75–100% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 30 July 200224 yrs ago
- Next accounts due
- 30 September 202627 days overdue
- Confirmation statement due
- 13 August 2027in 290 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72190
- Other research and experimental development on natural sciences and engineering
- Accounts type
- Group
- Size band
- SmallCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | £12.78m | £1.15m | £15.50m | — | — | — | 31 |
| 31 December 2023 | £11.52m | £1.59m | £14.33m | — | — | — | 45 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £12,784,684 at 31 December 2024
- Net assets up 10% or more on the prior period+10.9% vs prior period
- Cash at bank of £50,000 or moreCash £1,152,919
- Incorporated five or more years agoIncorporated 30 July 2002
- Register status is not ActiveActive - Proposal to Strike off
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 290 days
- Next accounts due27 days overdue
- Accounts period endNet assets £12.78m · group accounts
- Accounts period endNet assets £11.52m · group accounts
- Incorporated
Similar companies in Milton Keynes
- QUANTIG LTDMilton Keynes · inc. Nov 2002
- CAMFRIDGE LIMITEDMilton Keynes · inc. May 2003
- EXPLICIT DESIGNS LIMITEDMilton Keynes · inc. Sept 2003
- OCCAS LIMITEDBedford · inc. Apr 2004
- TCHAMBAK LIMITEDMilton Keynes · inc. Jan 2005
- CRANFIELD DEFENCE & SECURITY SERVICES LIMITEDWharley End · inc. Jan 2005
All companies incorporated on 30 July 2002 · in Jul 2002.
Reminders for EMMES BIOPHARMA UK LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.